Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals

International Immunology

Volumn 21, Issue 1, 2009, Pages 63-71

  Yang, Junbao ^a   James, Eddie ^a   Roti, Michelle ^a   Huston, Laurie ^a   Gebe, John A ^a   Kwok, William W ^a,b  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

MHC class II tetramer; Tetramer guided epitope mapping

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; INTERLEUKIN 13; TETRAMER; VIRUS SPIKE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; EPIDEMIC; EPITOPE MAPPING; HUMAN; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SARS CORONAVIRUS; SEQUENCE HOMOLOGY; SEVERE ACUTE RESPIRATORY SYNDROME; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; EPITOPE MAPPING; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNODOMINANT EPITOPES; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL ENVELOPE PROTEINS;

EID: 58049192952     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxn124     Document Type: Article

References (33)

1. Becker, K., Hu, Y. and Biller-Andorno, N. 2006. Infectious diseases - a global challenge. Int J Med Microbiol. 296:179.
2. Jones, K. E., Patel, N. G., Levy, M. A. et al. 2008. Global trends in emerging infectious diseases. Nature 451:991.
3. Ridley, R. G. 2004. Research on infectious diseases requires better coordination. Nat Med. 10:S137.
4. Fouchier, R. A., Kuiken, T., Schutten, M. et al. 2003. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423:240.
5. Ksiazek, T. G., Erdman, D., Goldsmith, C. S. et al. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 348:1953.
6. Kuiken, T., Fouchier, R. A., Schutten, M. et al. 2003. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362:263.
7. Peiris, J. S., Lai, S. T., Poon, L. L. et al. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319.
8. Stadler, K., Masignani, V., Eickmann, M. et al. 2003. SARS - beginning to understand a new virus. Nat Rev Microbiol. 1:209.
9. Eickmann, M., Becker, S., Klenk, H. D. et al. 2003. Phylogeny of the SARS coronavirus. Science 302:1504.
10. Liang, G., Chen, Q., Xu, J. et al. 2004. Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China. Emerg Infect Dis. 10:1774.
11. Lina, B., Valette, M., Foray, S. et al. 1996. Surveillance of community-acquired viral infections due to respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995. J Clin Microbiol. 34:3007.
12. Makela, M. J., Puhakka, T., Ruuskanen, O. et al. 1998. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol. 36:539.
13. Satija, N. and Lal, S. K. 2007. The molecular biology of SARS coronavirus. Ann N Y Acad Sci. 1102:26.
14. Rota, P. A., Oberste, M. S., Monroe, S. S. et al. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:1394.
15. de Haan, C. A., Volders, H., Koetzner, C. A., Masters, P. S. and Rottier, P. J. 2002. Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization. J Virol. 76:12491.
16. Broer, R., Boson, B., Spaan, W., Cosset, F. L. and Corver, J. 2006. Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry. J Virol. 80:1302.
17. Li, W., Moore, M. J., Vasilieva, N. et al. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450.
18. Gao, W., Tamin, A., Soloff, A. et al. 2003. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 362:1895.
19. Zhong, X., Yang, H., Guo, Z. F. et al. 2005. B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein. J Virol. 79:3401.
20. Buchholz, U. J., Bukreyev, A., Yang, L. et al. 2004. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci USA. 101:9804.
21. Tsao, Y. P., Lin, J. Y., Jan, J. T. et al. 2006. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins. Biochem Biophys Res Commun. 344:63.
22. Wang, B., Chen, H., Jiang, X. et al. 2004. Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein. Blood 104:200.
23. Wang, Y. D., Sin, W. Y., Xu, G. B. et al. 2004. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS. J Virol. 78:5612.
24. Zhou, M., Xu, D., Li, X. et al. 2006. Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes. J Immunol. 177:2138.
25. Chen, H., Hou, J., Jiang, X. et al. 2005. Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals. J Immunol. 175:591.
26. Zhao, J., Huang, Q., Wang, W., Zhang, Y., Lv, P. and Gao, X. M. 2007. Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol. 81:6079.
27. Libraty, D. H., O'Neil, K. M., Baker, L. M., Acosta, L. P. and Olveda, R. M. 2007. Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection. Virology 368:317.
28. Novak, E. J., Liu, A. W., Nepom, G. T. and Kwok, W. W. 1999. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferatingin response to influenza A antigen. J Clin Invest. 104:R63.
29. Novak, E. J., Liu, A. W., Gebe, J. A. et al. 2001. Tetramer-guided epitope mapping: Rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens. J Immunol. 166:6665.
30. Yang, J., Danke, N. A., Berger, D. et al. 2006. Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects. J Immunol. 176:2781.
31. Yang, J., James, E. A., Huston, L., Danke, N. A., Liu, A. W. and Kwok, W. W. 2006. Multiplex mapping of CD4 T cell epitopes using class II tetramers. Clin Immunol. 120:21.
32. Kwok, W. W., Yang, J., James, E. et al. 008. The anthrax vaccine adsorbed vaccine generates protective antigen (PA)-specific CD4+ T cells with a phenotype distinct from that of naive PA T cells. Infect Immun. 76:4538.
33. Roti, M., Yang, J., Berger, D., Huston, L., James, E. A. and Kwok, W. W. 2008. Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus. J Immunol. 180:1758.